Medical cannabis is increasingly used by people with chronic neuropathic pain, often after standard treatments fall short. However, a major review update found no reliable, high-quality evidence that such products relieve pain beyond placebo.
Published in Cochrane Database of Systematic Reviews, a rigorous, globally trusted evidence library, the review update examined 21 randomized trials involving more than 2,100 adults—including six new studies published since its last update in 2018—and like last time, concluded that benefits of medical cannabis were inconsistent and side effects were common.
